A Study to Evaluate the Safety and Immunogenicity of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants
Clinical trial NCT02376426 · COMPLETED
Trial details
- NCT number
- NCT02376426
- Sponsor
- Crucell Holland BV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2015-09-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.